1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Digital Health Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Digital Health Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Trends
5.1.1. Increase in Adoption of Cloud-based Systems
5.1.2. Virtualization Technologies and Technological Advancements Add New Dimensions to Healthcare IT
5.2. Digital Therapeutic Business, Opportunities, and Entry Barriers for New Market Entrants
5.3. Qualitative Information on Business Models in Digital Health Market
5.4. Traditional Business Model: Challenges to Traditional Business Model
5.5. New Digital Health Business Model
5.6. Adoption of Digital Healthcare, by End-users
5.7. Impact Factor for Digital Therapeutic Demand
5.8. Global Healthcare Expenditure, by Major Countries
5.9. Digital Medicine Business Model
5.10. Factors Increasing Traction of Digital Therapeutic Products
5.10.1. Healthcare Costs
5.10.2. Value-based Payment Models
5.10.3. Venture Funding
5.10.4. Others
6. Global Digital Health Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017-2031
6.3.1. Healthcare Information Systems
6.3.1.1. Clinical Solutions
6.3.1.1.1. EHR/EMR
6.3.1.1.2. Clinical Decision Support System (CDSS)
6.3.1.1.3. Computerized Physician Order Entry (CPOE)
6.3.1.1.4. mHealth
6.3.1.1.4.1. Connected Medical Devices
6.3.1.1.4.2. mHealth Components
6.3.1.1.4.2.1. Fitness App
6.3.1.1.4.2.2. Medical Reference
6.3.1.1.4.2.3. Fitness App
6.3.1.1.4.2.4. Wellness
6.3.1.1.4.2.5. Medical Condition Management
6.3.1.1.4.2.6. Nutrition
6.3.1.1.4.2.7. Remote Consultation
6.3.1.1.4.2.8. Reminders and Alerts
6.3.1.1.4.2.9. Others
6.3.1.1.5. Telehealth
6.3.1.1.6. Population Health Management
6.3.1.1.7. Others
6.3.1.2. Non-clinical Solutions
6.3.2. Wearable Devices
6.3.2.1. Diagnostic and Monitoring Devices
6.3.2.2. Digital Therapeutic Devices
6.3.2.2.1. Pain Management Devices
6.3.2.2.2. Rehabilitation Devices
6.3.2.2.3. Respiratory Therapy Devices
6.3.2.2.4. Insulin Pumps
6.4. Market Attractiveness Analysis, by Product
7. Global Digital Health Market Analysis and Forecast, by Component
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Component, 2017-2031
7.3.1. Software
7.3.2. Hardware
7.3.3. Services
7.4. Market Attractiveness Analysis, by Component
8. Global Digital Health Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017-2031
8.3.1. B2C
8.3.1.1. Patients
8.3.1.2. Caregivers
8.3.2. B2B
8.3.2.1. Providers
8.3.2.2. Payers
8.3.2.3. Employers
8.3.2.4. Pharmaceutical Companies
8.3.2.5. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Digital Health Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017-2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Digital Health Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017-2031
10.2.1. Healthcare Information Systems
10.2.1.1. Clinical Solutions
10.2.1.1.1. EHR/EMR
10.2.1.1.2. Clinical Decision Support System (CDSS)
10.2.1.1.3. Computerized Physician Order Entry (CPOE)
10.2.1.1.4. mHealth
10.2.1.1.4.1. Connected Medical Devices
10.2.1.1.4.2. mHealth Components
10.2.1.1.4.2.1. Fitness App
10.2.1.1.4.2.2. Medical Reference
10.2.1.1.4.2.3. Fitness App
10.2.1.1.4.2.4. Wellness
10.2.1.1.4.2.5. Medical Condition Management
10.2.1.1.4.2.6. Nutrition
10.2.1.1.4.2.7. Remote Consultation
10.2.1.1.4.2.8. Reminders and Alerts
10.2.1.1.4.2.9. Others
10.2.1.1.5. Telehealth
10.2.1.1.6. Population Health Management
10.2.1.1.7. Others
10.2.1.2. Non-clinical Solutions
10.2.2. Wearable Devices
10.2.2.1. Diagnostic and Monitoring Devices
10.2.2.2. Digital Therapeutic Devices
10.2.2.2.1. Pain Management Devices
10.2.2.2.2. Rehabilitation Devices
10.2.2.2.3. Respiratory Therapy Devices
10.2.2.2.4. Insulin Pumps
10.3. Market Value Forecast, by Component, 2017-2031
10.3.1. Software
10.3.2. Hardware
10.3.3. Services
10.4. Market Value Forecast, by End-user, 2017-2031
10.4.1. B2C
10.4.1.1. Patients
10.4.1.2. Caregivers
10.4.2. B2B
10.4.2.1. Providers
10.4.2.2. Payers
10.4.2.3. Employers
10.4.2.4. Pharmaceutical Companies
10.4.2.5. Others
10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Component
10.6.3. By End-user
10.6.4. By Country
11. Europe Digital Health Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017-2031
11.2.1. Healthcare Information Systems
11.2.1.1. Clinical Solutions
11.2.1.1.1. EHR/EMR
11.2.1.1.2. Clinical Decision Support System (CDSS)
11.2.1.1.3. Computerized Physician Order Entry (CPOE)
11.2.1.1.4. mHealth
11.2.1.1.4.1. Connected Medical Devices
11.2.1.1.4.2. mHealth Components
11.2.1.1.4.2.1. Fitness App
11.2.1.1.4.2.2. Medical Reference
11.2.1.1.4.2.3. Fitness App
11.2.1.1.4.2.4. Wellness
11.2.1.1.4.2.5. Medical Condition Management
11.2.1.1.4.2.6. Nutrition
11.2.1.1.4.2.7. Remote Consultation
11.2.1.1.4.2.8. Reminders and Alerts
11.2.1.1.4.2.9. Others
11.2.1.1.5. Telehealth
11.2.1.1.6. Population Health Management
11.2.1.1.7. Others
11.2.1.2. Non-clinical Solutions
11.2.2. Wearable Devices
11.2.2.1. Diagnostic and Monitoring Devices
11.2.2.2. Digital Therapeutic Devices
11.2.2.2.1. Pain Management Devices
11.2.2.2.2. Rehabilitation Devices
11.2.2.2.3. Respiratory Therapy Devices
11.2.2.2.4. Insulin Pumps
11.3. Market Value Forecast, by Component, 2017-2031
11.3.1. Software
11.3.2. Hardware
11.3.3. Services
11.4. Market Value Forecast, by End-user, 2017-2031
11.4.1. B2C
11.4.1.1. Patients
11.4.1.2. Caregivers
11.4.2. B2B
11.4.2.1. Providers
11.4.2.2. Payers
11.4.2.3. Employers
11.4.2.4. Pharmaceutical Companies
11.4.2.5. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Component
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Digital Health Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017-2031
12.2.1. Healthcare Information Systems
12.2.1.1. Clinical Solutions
12.2.1.1.1. EHR/EMR
12.2.1.1.2. Clinical Decision Support System (CDSS)
12.2.1.1.3. Computerized Physician Order Entry (CPOE)
12.2.1.1.4. mHealth
12.2.1.1.4.1. Connected Medical Devices
12.2.1.1.4.2. mHealth Components
12.2.1.1.4.2.1. Fitness App
12.2.1.1.4.2.2. Medical Reference
12.2.1.1.4.2.3. Fitness App
12.2.1.1.4.2.4. Wellness
12.2.1.1.4.2.5. Medical Condition Management
12.2.1.1.4.2.6. Nutrition
12.2.1.1.4.2.7. Remote Consultation
12.2.1.1.4.2.8. Reminders and Alerts
12.2.1.1.4.2.9. Others
12.2.1.1.5. Telehealth
12.2.1.1.6. Population Health Management
12.2.1.1.7. Others
12.2.1.2. Non-clinical Solutions
12.2.2. Wearable Devices
12.2.2.1. Diagnostic and Monitoring Devices
12.2.2.2. Digital Therapeutic Devices
12.2.2.2.1. Pain Management Devices
12.2.2.2.2. Rehabilitation Devices
12.2.2.2.3. Respiratory Therapy Devices
12.2.2.2.4. Insulin Pumps
12.3. Market Value Forecast, by Component, 2017-2031
12.3.1. Software
12.3.2. Hardware
12.3.3. Services
12.4. Market Value Forecast, by End-user, 2017-2031
12.4.1. B2C
12.4.1.1. Patients
12.4.1.2. Caregivers
12.4.2. B2B
12.4.2.1. Providers
12.4.2.2. Payers
12.4.2.3. Employers
12.4.2.4. Pharmaceutical Companies
12.4.2.5. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Component
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Digital Health Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017-2031
13.2.1. Healthcare Information Systems
13.2.1.1. Clinical Solutions
13.2.1.1.1. EHR/EMR
13.2.1.1.2. Clinical Decision Support System (CDSS)
13.2.1.1.3. Computerized Physician Order Entry (CPOE)
13.2.1.1.4. mHealth
13.2.1.1.4.1. Connected Medical Devices
13.2.1.1.4.2. mHealth Components
13.2.1.1.4.2.1. Fitness App
13.2.1.1.4.2.2. Medical Reference
13.2.1.1.4.2.3. Fitness App
13.2.1.1.4.2.4. Wellness
13.2.1.1.4.2.5. Medical Condition Management
13.2.1.1.4.2.6. Nutrition
13.2.1.1.4.2.7. Remote Consultation
13.2.1.1.4.2.8. Reminders and Alerts
13.2.1.1.4.2.9. Others
13.2.1.1.5. Telehealth
13.2.1.1.6. Population Health Management
13.2.1.1.7. Others
13.2.1.2. Non-clinical Solutions
13.2.2. Wearable Devices
13.2.2.1. Diagnostic and Monitoring Devices
13.2.2.2. Digital Therapeutic Devices
13.2.2.2.1. Pain Management Devices
13.2.2.2.2. Rehabilitation Devices
13.2.2.2.3. Respiratory Therapy Devices
13.2.2.2.4. Insulin Pumps
13.3. Market Value Forecast, by Component, 2017-2031
13.3.1. Software
13.3.2. Hardware
13.3.3. Services
13.4. Market Value Forecast, by End-user, 2017-2031
13.4.1. B2C
13.4.1.1. Patients
13.4.1.2. Caregivers
13.4.2. B2B
13.4.2.1. Providers
13.4.2.2. Payers
13.4.2.3. Employers
13.4.2.4. Pharmaceutical Companies
13.4.2.5. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Component
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Digital Health Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017-2031
14.2.1. Healthcare Information Systems
14.2.1.1. Clinical Solutions
14.2.1.1.1. EHR/EMR
14.2.1.1.2. Clinical Decision Support System (CDSS)
14.2.1.1.3. Computerized Physician Order Entry (CPOE)
14.2.1.1.4. mHealth
14.2.1.1.4.1. Connected Medical Devices
14.2.1.1.4.2. mHealth Components
14.2.1.1.4.2.1. Fitness App
14.2.1.1.4.2.2. Medical Reference
14.2.1.1.4.2.3. Fitness App
14.2.1.1.4.2.4. Wellness
14.2.1.1.4.2.5. Medical Condition Management
14.2.1.1.4.2.6. Nutrition
14.2.1.1.4.2.7. Remote Consultation
14.2.1.1.4.2.8. Reminders and Alerts
14.2.1.1.4.2.9. Others
14.2.1.1.5. Telehealth
14.2.1.1.6. Population Health Management
14.2.1.1.7. Others
14.2.1.2. Non-clinical Solutions
14.2.2. Wearable Devices
14.2.2.1. Diagnostic and Monitoring Devices
14.2.2.2. Digital Therapeutic Devices
14.2.2.2.1. Pain Management Devices
14.2.2.2.2. Rehabilitation Devices
14.2.2.2.3. Respiratory Therapy Devices
14.2.2.2.4. Insulin Pumps
14.3. Market Value Forecast, by Component, 2017-2031
14.3.1. Software
14.3.2. Hardware
14.3.3. Services
14.4. Market Value Forecast, by End-user, 2017-2031
14.4.1. B2C
14.4.1.1. Patients
14.4.1.2. Caregivers
14.4.2. B2B
14.4.2.1. Providers
14.4.2.2. Payers
14.4.2.3. Employers
14.4.2.4. Pharmaceutical Companies
14.4.2.5. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Component
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company, 2022
15.3. Company Profiles
15.3.1. Agfa-Gevaert N.V.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Cerner Corporation
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Allscripts Healthcare Solutions, Inc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. McKesson Corporation
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Philips Healthcare
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. GE Healthcare
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Siemens Healthineers
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Epic Systems Corporation.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Merative
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Alphabet Inc.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
15.3.11. Qualcomm, Inc.
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. Financial Overview
15.3.11.4. SWOT Analysis
15.3.11.5. Strategic Overview
15.3.12. UnitedHealth Group (Optum)
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Product Portfolio
15.3.12.3. Financial Overview
15.3.12.4. SWOT Analysis
15.3.12.5. Strategic Overview
15.3.13. Cisco Systems, Inc.
15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.13.2. Product Portfolio
15.3.13.3. Financial Overview
15.3.13.4. SWOT Analysis
15.3.13.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
